TrialBritish journal of cancer2020

Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours.

Corran Roberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.